Pinnacle Associates LTD Adverum Biotechnologies, Inc. Transaction History

Pinnacle Associates LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 02, 2021	SELL	$3.36 - $10.56 $174,585 - $548,697	-51,960 Closed	0 $0
Q1 2021 May 12, 2021	SELL	$9.26 - $14.36 $2,731 - $4,236	-295 Reduced 0.56%	51,960 $512,000
Q4 2020 Jan 26, 2021	BUY	$9.84 - $14.26 $5,412 - $7,843	550 Added 1.06%	52,255 $566,000
Q3 2020 Oct 23, 2020	BUY	$10.3 - $21.64 $32,960 - $69,248	3,200 Added 6.6%	51,705 $533,000
Q2 2020 Aug 14, 2020	BUY	$8.53 - $25.64 $413,747 - $1.24 Million	48,505 New	48,505 $1.01 Million

524K

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $471M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Pinnacle Associates LTD, based on Form 13F filings with the SEC.

Stay updated on Pinnacle Associates LTD with notifications on news.